148 related articles for article (PubMed ID: 25213695)
1. miR149 rs71428439 polymorphism and risk of clear cell renal cell carcinoma: a case-control study.
Wang Z; Wei M; Ren Y; Liu H; Wang M; Shi K; Jiang H
Tumour Biol; 2014 Dec; 35(12):12127-30. PubMed ID: 25213695
[TBL] [Abstract][Full Text] [Related]
2. Methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C and G1793A polymorphisms: association with risk for clear cell renal cell carcinoma and tumour behaviour in men.
Safarinejad MR; Shafiei N; Safarinejad S
Clin Oncol (R Coll Radiol); 2012 May; 24(4):269-81. PubMed ID: 21489764
[TBL] [Abstract][Full Text] [Related]
3. Functional variants in the low-density lipoprotein receptor gene are associated with clear cell renal cell carcinoma susceptibility.
Zhang GM; Wang MY; Liu YN; Zhu Y; Wan FN; Wei QY; Ye DW
Carcinogenesis; 2017 Dec; 38(12):1241-1248. PubMed ID: 29029037
[TBL] [Abstract][Full Text] [Related]
4. XRCC3 Thr241Met and XPD Lys751Gln gene polymorphisms and risk of clear cell renal cell carcinoma.
Loghin A; Bănescu C; Nechifor-Boila A; Chibelean C; Orsolya M; Nechifor-Boila A; Tripon F; Voidazan S; Borda A
Cancer Biomark; 2016; 16(2):211-7. PubMed ID: 26682510
[TBL] [Abstract][Full Text] [Related]
5. ADIPOQ polymorphism rs182052 is associated with clear cell renal cell carcinoma.
Zhang G; Gu C; Zhu Y; Luo L; Dong D; Wan F; Zhang H; Shi G; Sun L; Ye D
Cancer Sci; 2015 Jun; 106(6):687-691. PubMed ID: 25827778
[TBL] [Abstract][Full Text] [Related]
6. Combined effects of DNA methyltransferase 1 and 3A polymorphisms and urinary total arsenic levels on the risk for clear cell renal cell carcinoma.
Yang SM; Huang CY; Shiue HS; Pu YS; Hsieh YH; Chen WJ; Lin YC; Hsueh YM
Toxicol Appl Pharmacol; 2016 Aug; 305():103-110. PubMed ID: 27292127
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor binding protein-3 (IGFBP-3) gene variants are associated with renal cell carcinoma.
Safarinejad MR
BJU Int; 2011 Sep; 108(5):762-70. PubMed ID: 21314884
[TBL] [Abstract][Full Text] [Related]
8. The miR(21/10b) ratio as a prognostic marker in clear cell renal cell carcinoma.
Fritz HKM; Lindgren D; Ljungberg B; Axelson H; Dahlbäck B
Eur J Cancer; 2014 Jul; 50(10):1758-1765. PubMed ID: 24793999
[TBL] [Abstract][Full Text] [Related]
9. Variants in angiogenesis-related genes and the risk of clear cell renal cell carcinoma.
Qin C; Chen J; Li J; Ju X; Zhang S; Cao Q; Han Z; Li P; Shao P; Wang M; Zhang Z; Gu M; Zhang W; Yin C
Mutagenesis; 2014 Nov; 29(6):419-25. PubMed ID: 25239121
[TBL] [Abstract][Full Text] [Related]
10. Polymorphism in protein tyrosine phosphatase receptor delta is associated with the risk of clear cell renal cell carcinoma.
Du Y; Su T; Tan X; Li X; Xie J; Wang G; Shen J; Hou J; Cao G
Gene; 2013 Jan; 512(1):64-9. PubMed ID: 23069849
[TBL] [Abstract][Full Text] [Related]
11. A novel functional polymorphism of GSTM3 reduces clear cell renal cell carcinoma risk through enhancing its expression by interfering miR-556 binding.
Wang Y; Yang ZY; Chen YH; Li F; Shen H; Yu Y; Huang HY; Shen ZY
J Cell Mol Med; 2018 Jun; 22(6):3005-3015. PubMed ID: 29569387
[TBL] [Abstract][Full Text] [Related]
12. One-carbon metabolism pathway gene variants and risk of clear cell renal cell carcinoma in a Chinese population.
Zhang L; Meng X; Ju X; Cai H; Li P; Cao Q; Shao P; Qin C; Yin C
PLoS One; 2013; 8(11):e81129. PubMed ID: 24278388
[TBL] [Abstract][Full Text] [Related]
13. [Polymorphism at the miR-502 binding site in the 3' untranslated region of SET8 gene is associated with the risk of clear cell renal cell carcinoma].
Xu JS; Bai YL; Zhang JX; Cui LW; Zhang HR; Zhang SL
Zhonghua Zhong Liu Za Zhi; 2016 Jun; 38(6):476-80. PubMed ID: 27346408
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of miR-181a in clear cell renal cell carcinoma is associated with lower KLF6 expression, enhanced cell proliferation, accelerated cell cycle transition, and diminished apoptosis.
Lei Z; Ma X; Li H; Zhang Y; Gao Y; Fan Y; Li X; Chen L; Xie Y; Chen J; Wu S; Tang L; Zhang X
Urol Oncol; 2018 Mar; 36(3):93.e23-93.e37. PubMed ID: 29066014
[TBL] [Abstract][Full Text] [Related]
15. CTLA-4 and CD28 genes' polymorphisms and renal cell carcinoma susceptibility in the Polish population--a prospective study.
Tupikowski K; Partyka A; Kolodziej A; Dembowski J; Debinski P; Halon A; Zdrojowy R; Frydecka I; Karabon L
Tissue Antigens; 2015 Nov; 86(5):353-61. PubMed ID: 26403483
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-185 inhibits cell proliferation and induces cell apoptosis by targeting VEGFA directly in von Hippel-Lindau-inactivated clear cell renal cell carcinoma.
Ma X; Shen D; Li H; Zhang Y; Lv X; Huang Q; Gao Y; Li X; Gu L; Xiu S; Bao X; Duan J; Zhang X
Urol Oncol; 2015 Apr; 33(4):169.e1-11. PubMed ID: 25700976
[TBL] [Abstract][Full Text] [Related]
17. Genetic Variants in Caveolin-1 and RhoA/ROCK1 Are Associated with Clear Cell Renal Cell Carcinoma Risk in a Chinese Population.
Zhao R; Liu K; Huang Z; Wang J; Pan Y; Huang Y; Deng X; Liu J; Qin C; Cheng G; Hua L; Li J; Yin C
PLoS One; 2015; 10(6):e0128771. PubMed ID: 26066055
[TBL] [Abstract][Full Text] [Related]
18. miRNA polymorphisms (miR‑146a, miR‑149, miR‑196a2 and miR‑499) are associated with the risk of coronary artery disease.
Sung JH; Kim SH; Yang WI; Kim WJ; Moon JY; Kim IJ; Cha DH; Cho SY; Kim JO; Kim KA; Kim OJ; Lim SW; Kim NK
Mol Med Rep; 2016 Sep; 14(3):2328-42. PubMed ID: 27430349
[TBL] [Abstract][Full Text] [Related]
19. Inverse correlation of miR-27a-3p and CDH5 expression serves as a diagnostic biomarker of proliferation and metastasis of clear cell renal carcinoma.
Wang Y; Zhou X; Han P; Lu Y; Zhong X; Yang Y; Li D; Liu D; Li Q; Pan N; Mo Y; Luo W; Li P; Zhou X; Liudmila M
Pathol Res Pract; 2021 Apr; 220():153393. PubMed ID: 33740544
[TBL] [Abstract][Full Text] [Related]
20. Effect of a functional polymorphism in the pre-miR-146a gene on the risk and prognosis of renal cell carcinoma.
Huang Z; Lu Z; Tian J; Wang G; Gao Z
Mol Med Rep; 2015 Nov; 12(5):6997-7004. PubMed ID: 26323945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
